Dawn Kelly-Sullivan

561 total citations
10 papers, 396 citations indexed

About

Dawn Kelly-Sullivan is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Dawn Kelly-Sullivan has authored 10 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Surgery. Recurrent topics in Dawn Kelly-Sullivan's work include Cannabis and Cannabinoid Research (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Dawn Kelly-Sullivan is often cited by papers focused on Cannabis and Cannabinoid Research (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Dawn Kelly-Sullivan collaborates with scholars based in United States. Dawn Kelly-Sullivan's co-authors include Shawn C. Black, Audrey L. Hildebrandt, George M. Abouna, Ismail H. Al-Abdullah, M. S. A. Kumar, Jeffrey H. Loose, Karen Ward, Dennis O. Scott, Rebecca E. O’Connor and Robert L. Dow and has published in prestigious journals such as Biochemical and Biophysical Research Communications, American Journal of Physiology-Endocrinology and Metabolism and European Journal of Pharmacology.

In The Last Decade

Dawn Kelly-Sullivan

10 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn Kelly-Sullivan United States 9 186 105 86 74 73 10 396
A. E. Pontiroli Italy 12 32 0.2× 165 1.6× 24 0.3× 128 1.7× 21 0.3× 24 415
P Konturek Germany 10 162 0.9× 168 1.6× 28 0.3× 57 0.8× 14 377
Malene Hollingdal Denmark 13 38 0.2× 413 3.9× 34 0.4× 501 6.8× 4 0.1× 22 760
P. Demol Germany 11 29 0.2× 173 1.6× 93 1.1× 59 0.8× 5 0.1× 43 322
Daniela Ibarra Gasparini Italy 6 125 0.7× 26 0.2× 22 0.3× 93 1.3× 6 317
Claire E. Thomas United States 8 106 0.6× 19 0.2× 76 0.9× 33 0.4× 22 317
Lena Brändén Sweden 9 54 0.3× 111 1.1× 26 0.3× 27 0.4× 13 319
К.-D. Kohnert Germany 9 18 0.1× 182 1.7× 15 0.2× 134 1.8× 40 0.5× 43 315
Jose Gasalla-Herraiz United States 11 67 0.4× 67 0.6× 57 0.7× 120 1.6× 15 438
Renate E. van Genugten Netherlands 10 42 0.2× 113 1.1× 12 0.1× 324 4.4× 10 0.1× 14 431

Countries citing papers authored by Dawn Kelly-Sullivan

Since Specialization
Citations

This map shows the geographic impact of Dawn Kelly-Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Kelly-Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Kelly-Sullivan more than expected).

Fields of papers citing papers by Dawn Kelly-Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Kelly-Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Kelly-Sullivan. The network helps show where Dawn Kelly-Sullivan may publish in the future.

Co-authorship network of co-authors of Dawn Kelly-Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Kelly-Sullivan. A scholar is included among the top collaborators of Dawn Kelly-Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Kelly-Sullivan. Dawn Kelly-Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dow, Robert L., Philip A. Carpino, John R. Hadcock, et al.. (2012). Design of a Potent CB1Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted Agents. ACS Medicinal Chemistry Letters. 3(5). 397–401. 36 indexed citations
2.
Hadcock, John R., Philip A. Carpino, Philip A. Iredale, et al.. (2010). Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) Receptor Antagonist. BMC Pharmacology. 10(1). 9–9. 12 indexed citations
3.
Hadcock, John R., David A. Griffith, Robert L. Dow, et al.. (2010). In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity. Biochemical and Biophysical Research Communications. 394(2). 366–371. 20 indexed citations
4.
Black, Shawn C., Dawn Kelly-Sullivan, Sergei Timofeevski, et al.. (2008). Pharmacological characterization of a small molecule inhibitor of c-Jun kinase. American Journal of Physiology-Endocrinology and Metabolism. 295(5). E1142–E1151. 22 indexed citations
5.
Hildebrandt, Audrey L., Dawn Kelly-Sullivan, & Shawn C. Black. (2003). Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. European Journal of Pharmacology. 462(1-3). 125–132. 157 indexed citations
6.
Hildebrandt, Audrey L., Dawn Kelly-Sullivan, & Shawn C. Black. (2002). Validation of a high-resolution X-ray computed tomography system to measure murine adipose tissue depot mass in situ and longitudinally. Journal of Pharmacological and Toxicological Methods. 47(2). 99–106. 16 indexed citations
7.
Al-Abdullah, Ismail H., M. S. A. Kumar, Dawn Kelly-Sullivan, & George M. Abouna. (1995). Site for Unpurified Islet Transplantation is an Important Parameter for Determination of the Outcome of Graft Survival and Function. Cell Transplantation. 4(3). 297–305. 28 indexed citations
8.
Al-Abdullah, Ismail H., et al.. (1995). Autotransplantation of unpurified pancreatic islets of Langerhans into different sites in the canine model.. PubMed. 27(5). 2645–6. 2 indexed citations
9.
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. E. Pontiroli Breakdown of academic impact, for papers by P Konturek Breakdown of academic impact, for papers by Malene Hollingdal Breakdown of academic impact, for papers by P. Demol Breakdown of academic impact, for papers by Daniela Ibarra Gasparini Breakdown of academic impact, for papers by Claire E. Thomas Breakdown of academic impact, for papers by Lena Brändén Breakdown of academic impact, for papers by К.-D. Kohnert Breakdown of academic impact, for papers by Jose Gasalla-Herraiz Breakdown of academic impact, for papers by Renate E. van Genugten
Rankless by CCL
2026